These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6319053

  • 1. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N, Grossman A, Perry L, Tomlin S, Wass JA, Coy DH, Schally AV, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [Abstract] [Full Text] [Related]

  • 2. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S, Vasiliou V, Kokkoris P, Stavropoulos G, Thalassinos N.
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M, Shibasaki T, Shizume K, Kiyosawa Y, Odagiri E, Suda T, Yamaguchi H, Tsushima T, Demura H, Maeda T.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [Abstract] [Full Text] [Related]

  • 4. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H, Skare S, Frey H, Hanssen KF, Norman N.
    Acta Med Scand; 1985 Nov; 218(1):79-84. PubMed ID: 2996312
    [Abstract] [Full Text] [Related]

  • 5. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 6. Correlation between plasma levels of ACTH and cortisol in basal states and during the CRH test in normal subjects and patients with hypothalamo-pituitary disorders.
    Bando H, Zhang CY, Takada Y, Takahashi H, Yamasaki R, Saito S.
    Tokushima J Exp Med; 1991 Dec; 38(3-4):61-9. PubMed ID: 1668824
    [Abstract] [Full Text] [Related]

  • 7. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
    Müller OA, Hartwimmer J, Hauer A, Kaliebe T, Schopohl J, Stalla GK, von Werder K.
    Psychoneuroendocrinology; 1986 Dec; 11(1):49-60. PubMed ID: 3010360
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA, Stalla GK, von Werder K.
    Horm Res; 1987 Dec; 25(4):185-98. PubMed ID: 3034758
    [Abstract] [Full Text] [Related]

  • 9. [Studies for clinical application of ovine corticotropin-releasing factor].
    Kubo M.
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
    [Abstract] [Full Text] [Related]

  • 10. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):167-78. PubMed ID: 2854761
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K.
    Acta Neurochir (Wien); 1985 Aug; 75(1-4):49-59. PubMed ID: 2986422
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P, Dall'Asta C, Barbetta L, Re T, Passini E, Faglia G, Ambrosi B.
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [Abstract] [Full Text] [Related]

  • 13. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [Abstract] [Full Text] [Related]

  • 14. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T, Nakai Y, Koh T, Tsujii S, Inada M, Nishikawa M, Shinoda H, Kawai I, Takezawa N, Imura H.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
    [Abstract] [Full Text] [Related]

  • 15. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.